Abstract
Introduction Current evidence still does not support the role of vitamin B12 or vitamin D in age-associated cognitive impairment.
Objective Evaluate the association between vitamin B12 and D and cognitive function in elders.
Methodology Sample included 1733 individuals 60 years old and older, who participated in the SABE study that was carried out in Ecuador. Cognitive function was measured using abbreviated version of minimental state examination (MMSE). Vitamin B12 and D were measured in blood. Data were analyzed through linear regression models with restricted cubic splines (RCSs). Models were adjusted by sex, years of education, region (urban highland, urban coast, rural highlands, rural coast), socioeconomic status, and ethnicity.
Results Independently from sex, age, years of education, ethnicity, socioeconomic status and geographical zone of residence, we found that vitamin B12 but not vitamin D levels were associated with cognitive function in a representative group of Ecuadorian elders. Elders with lower levels of vitamin B12 showed lower MMSE scores in comparison to elders with higher levels of vitamin B12. Moreover, a statically significant non linear interaction was found between vitamin B12 and age with respect to cognitive function. In this way, we observed that in elders 75 years old and older whose levels of vitamin B12 were 271 pg/ml or less, the drop of cognitive function was particularly steep in comparison to elders whose levels of vitamin B12 were 647 pg/ml or more.
Conclusions Low levels of vitamin B12 but not of vitamin D are associated with low cognitive functioning.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The present study was performed using data of the SABE study that was carried out in Ecuador between 2009 and 2011. Data is publicly available and can be accessed via https://anda.inec.gob.ec/anda/index.php/catalog/292
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.